141 related articles for article (PubMed ID: 22735065)
1. Current guidelines for cervical cancer screening.
Schwaiger C; Aruda M; LaCoursiere S; Rubin R
J Am Acad Nurse Pract; 2012 Jul; 24(7):417-24. PubMed ID: 22735065
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus in women over 40: implications for practice and recommendations for screening.
Montgomery K; Bloch JR
J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women.
Donati S; Giambi C; Declich S; Salmaso S; Filia A; Ciofi degli Atti ML; Alibrandi MP; Brezzi S; Carozzi F; Collina N; Franchi D; Lattanzi A; Meda M; Minna MC; Nannini R; Gallicchio G; Bella A;
Vaccine; 2012 Mar; 30(12):2075-82. PubMed ID: 22300719
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
Datta SD; Saraiya M
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
9. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
11. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
12. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
14. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
15. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
Almonte M; Sasieni P; Cuzick J
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
[TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
17. Young women's perspectives on cervical cancer prevention in Appalachian Kentucky.
Head KJ; Cohen EL
Qual Health Res; 2012 Apr; 22(4):476-87. PubMed ID: 22068039
[TBL] [Abstract][Full Text] [Related]
18. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour?
Mather T; McCaffery K; Juraskova I
Vaccine; 2012 May; 30(21):3196-201. PubMed ID: 22425789
[TBL] [Abstract][Full Text] [Related]
19. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
Hall B; Howard K; McCaffery K
Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
[TBL] [Abstract][Full Text] [Related]
20. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
